2022 Speakers

Join 35+ Industry-Leading Speakers

Agnete Fredriksen

Chief Innovation & Strategy Officer

Nykode Therapeutics

Andrew Allen

CEO

Gritstone bio

Aude-Helene Capietto

Senior Principal Scientific Researcher, Cancer Immunology

Genentech

Barbara Loesch

Head of Technology and Innovation

Medigene

David Gfeller

Assistant Professor

University of Lausanne

Elisa Scarselli

Chief Scientific Officer

Nouscom Srl

Eric Halioua

President & CEO

PDC*line Pharma

Erik Wiklund

Chief Executive Officer

Targovax ASA

Florian Kast

Postdoctoral Researcher

Roche

Guido Leoni

Head of Bioinformatics

Nouscom Srl

Heinrich Haas

Vice President Formulation and Drug Development

BioNTech AG

Heinz Lubenau

Chief Executive Officer & Co-Founder

Vaximm GmbH

Hugh Salter

Chief Scientific Officer

Anocca AB

Jean-Marc Limacher

Co-Founder, President & Chief Medical Officer

Odimma therapeutics

Jeffrey Bockman

Executive Vice President & Oncology Practice Head

Cello Health BioConsulting

Jens Kringelum

Jens Kringelum

Director, Genomic Immuno-Oncology

Evaxion Biotech

Jeroen van Bergen

Chief Scientific Officer

Immunetune

Jessica Matta

Co-Founder & Chief Executive Officer & Chief Scientific Officer

Odimma therapeutics

Kaidre Bendjama

Kaidre Bendjama

Project Leader - Personalised Cancer Vaccines

Transgene

Kostas

Kostas Kosmatopoulos

CEO

Vaxon Biotech

Lone Ottesen

Chief Medical Officer

Targovax

Matthew Davies

Head Of Bioinformatics

Enara Bio

Maximilian Bosch

Project Manager

Lung Center, Cantonal Hospital St.Gallen, Switzerland

Nicola Ternette

Principle Investigator, Antigen Discovery

University of Oxford

Peter Joyce

Chief Executive Officer & Co-founder

Grey Wolf Therapeutics Ltd.

Peter Sondermann

CEO

Tacalyx GmbH

Philip Arlen

Philip Arlen

President & Chief Executive Officer

Precision BioLogic

Sari Pesonen

Co-Founder & Chief Scientific Officer

Valo Therapeutics

Sijme Zeilemaker

Chief Executive Officer

Immunetune

Stephane Depil

Onco-Hematology Specialist Immuno-Oncology & Cancer Immunotherapy

Centre Leon Berard

Thomas Sandal

CTO R&D

PokeAcell

Wigard Kloosterman

Chief Scientific Officer Frame

Frame Therapeutics